TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
RGEN

Repligen Corporation

Healthcare · Medical Instruments & Supplies

178.20$ +3.1% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

Repligen Corporation (RGEN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 738 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement RGEN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
64 84 105 141 194 270 366 671 802 639 634 738
28 35 47 67 86 132 172 279 346 355 360 391
36 48 57 74 108 138 194 391 456 284 275 348
5.6 5.7 7.4 8.7 16 19 20 34 44 43 43 54
17 25 31 52 66 96 120 184 216 214 263 291
23 30 38 60 82 98 113 224 231 230 310 288
11 14 16 14 26 40 81 167 225 55 -35 60
0.0 0.0 3.8 6.4 6.7 9.3 12 13 3.0 10 23 23
11 13 12 7.2 21 26 59 154 219 64 -27 62
3.0 4.1 0.0 -21 4.8 4.7 -0.7 25 33 23 -1.5 13
8.2 9.3 12 28 17 21 60 128 186 42 -26 49
15 22 25 24 42 56 98 203 277 124 80 164

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?